Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Currently available antidepressants are effective in less than two thirds of depressed patients, with even lower remission rates in the context of co-morbid medical illness. A rapidly expanding evidence base suggests that maladaptive inflammatory immune responses may be a common pathophysiology underlying depression, particularly in the presence of a general medical condition. The inflammatory hypothesis of depression marks a significant shift away from monoamine-based approaches and is a major step towards developing novel treatments that directly target causal factors of depression. Many antidepressants exert anti-inflammatory effects and there is an emerging literature documenting the efficacy of anti-inflammatory agents as adjunctive treatments for depression. Identification of inflammatory biomarkers in depression will require a re-conceptualization of both the diagnostic phenomenology and the experimental approaches to studying multi-determined psychiatric disorders. In addition to their application in diagnosis, predicting prognosis, and monitoring severity and response to treatment, inflammatory biomarkers may serve as novel therapeutic targets in the treatment of depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence also demonstrates efficacy of TNF antagonists in subgroups with treatment-resistant depression.76,77”
From Cognitive Impairment in Major Depressive Disorder (2019) · cites this paper as [77]
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Several challenges in this field need to be addressed [8, 10, 25, 51 ], including 1) the diagnostic phenomenology or clinical variability within the syndrome of major depression; 2) the impact of biobehavioral variables on biomarker levels [52]; 3) the need to standardize methods of biological sample collection and as…”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Although the correlations between peripheral inflammatory markers and depression have not always been consistent [25], meta-analyses controlling for biobehavioral variables document that MDD is consistently associated with elevations in C-reactive protein, IL-1, IL-1 receptor antagonist, IL-6, and tumor necrosis facto…”
BackgroundInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 2×
“Peripheral cytokines then access the brain and initiate a mirrored central cytokine expression cascade, which may contribute to the pathophysiology of depression through actions on monoamine levels, increasing neuronal excitotoxicity, reducing brain trophic factors, and impairing autoregulatory endocrine pathways [9].”
BackgroundAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · cited 1×
“Although the correlations between peripheral inflammatory markers and depression have not always been consistent [25], meta-analyses controlling for biobehavioral variables document that MDD is consistently associated with elevations in C-reactive protein, IL-1, IL-1 receptor antagonist, IL-6, and tumor necrosis facto…”
BackgroundHasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1097 · Cited by 1,645 · cited 1×
“Major depressivedisorder (MDD) has a lifetimeprevalence of approximately 12% to 15% [ 1 ] and is second only to cardiovascular disease in disease burden based on disability-adjusted life-years [2].”
BackgroundChildhood maltreatment predicts adult inflammation in a life-course study
Danese, A., Pariante, C. M., Caspi, A., Taylor, A., & Poulton, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610362104 · Cited by 1,264 · cited 1×
“Recent work has also demonstrated that psychosocial stress, including early adversity, interpersonal conflict, or social isolation, can precipitate increases in cytokines and other inflammatory markers [13, 14].”
BackgroundImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195 · cited 5×
“Furthermore, cytokines stimulate the release of reactive oxygen and nitrogen species, which, combined with glutamate and quinolinic acid, can contribute to depression through brain excitotoxicity and suppression of neurogenesis, as well as protective factors such as brain-derived neurotrophic factor [12, 23, 24].”
BackgroundInfluentialTyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 1×
“There are also reports that individuals with autoimmune or inflammatory disorders who are treated with a TNF-α inhibitor experience a reduction in depressive symptoms [43–46].”
BackgroundThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · cited 1×
“In a meta-analysis of inflammatory biomarkers that included measures of cellular immunity, Zorrilla and colleagues [28] concluded that decreased natural killer cell cytotoxicity; decreased mitogen-stimulated lymphocyte proliferation; and increased IL-6, haptoglobin, and prostaglandin E2 are associated with MDD.”
BackgroundThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 1×
“From the award-winning observation in 1927 by Nobel laureate Julius Wagner-Jauregg that malaria inoculation could affect psychiatric functioning, to the “macrophage theory of depression” by Smith [7] in 1991, the role of inflammation in the pathophysiology of depression has been increasingly recognized and is now desc…”
Background
Cited by
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Vagal pathways for microbiome-brain-gut axis communication
Forsythe, P., Bienenstock, J., & Kunze, W. A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_5 · Cited by 576
“Immune system dysfunction has been linked to depression [32–34].”
BackgroundCognitive Impairment in Major Depressive Disorder
Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2019) · CNS Spectrums · doi:10.1017/s1092852918001207 · Cited by 320
The psychosocial burden of psoriatic arthritis
Husni, M. E., Merola, J. F., & Davin, S. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.05.010 · Cited by 181
Molecular biomarkers of depression
Gururajan, A., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.011 · Cited by 151
Metadata
- Authors
- Li, M., Soczynska, J. K., & Kennedy, S. H.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Li, Madeline
- Venue
- Current Psychiatry Reports
- Published
- 2011-06-14
- Volume
- 13
- Issue
- 5
- Pages
- 316-320
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- OpenAlex
- W2043049090
- Cited by
- 53
- References
- 60
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 2
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- depression, inflammatory markers, adjunctive therapy, comorbidities, antidepressant response, biomarker-based diagnosis, therapeutic target
- MeSH terms
- Anti-Inflammatory Agents, Antidepressive Agents, Depressive Disorder, Humans, Inflammation, Stress, Psychological, Biomarkers, Cytokines, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions. https://app.cochat.ai/papers/10.1007/s11920-011-0210-6
- The paper
- Li, M., Soczynska, J. K., & Kennedy, S. H. (2011). Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions. Current Psychiatry Reports. https://doi.org/10.1007/s11920-011-0210-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.